Images link psoriasis to other diseases

Despite many recent advances by specialists in understanding psoriasis, too many people, including some doctors, still believe that it is merely a skin problem. So says Dr. Nehal N. Mehta, whose latest research provides further evidence that psoriasis is more than skin deep.

Mehta, a preventive and nuclear cardiologist with the University of Pennsylvania Perelman School of Medicine, was lead author of a groundbreaking study, funded by the National Psoriasis Foundation, that used a sophisticated, highly advanced imaging technology to detect areas of inflammation in people with psoriasis.

As the researchers expected, the images did show inflamed skin and inflammation in blood vessels. But they were surprised to observe inflammation in other organs and joints in the patients with psoriasis, one of whom also had psoriatic arthritis. The evidence impressed Mehta and his associates, who believe the study provides further evidence that psoriasis and other inflammatory diseases are linked.

The images showed inflammation in the liver, joints, tendons and aorta, even though the study participants had no symptoms or apparent risk factors for diseases that affect those organs. The participants who did not have psoriasis did not show any increased inflammation in any of these locations.

The study, published in the Archives of Dermatology, adds to a growing body of evidence that people with psoriasis are at a higher risk for heart, joint and liver disease, even when they do not have any symptoms.

Mehta was especially interested to discover inflammation in the liver. "For the first time, a study showed liver inflammation is much higher in psoriasis patients when looking in real time," he said. This finding suggests why patients with psoriasis may have high cholesterol and blood sugars, as well as trouble with certain drugs, such as methotrexate or commonly used statin medications for cholesterol, which are metabolized by the liver.

'Seeing' inflammation

 Dr. Mehta standing by a highly sensitive PET/CT scanner used to obtain precise images of inflammation within the bodies of patients with psoriasis

For the study, Mehta's research team used a highly sensitive imaging technique called fluorodeoxyglucose positron emission tomography—computed tomography, or FDG-PET/CT, which produces images that detect the metabolic activity of tissues within the body. The study's purpose was to learn whether this technique could capture an image of inflammation beyond the skin in patients who have moderate to severe psoriasis to better understand why patients with psoriasis may be at higher risk for heart disease and diabetes.

The study produced two main findings. First, it showed that psoriasis as a disease affects the whole body, not just the skin (denoted by the arrows in the image on the previous page). It also showed that FDG-PET/CT imaging is effective for identifying inflammation in the blood vessels, joints and liver, as well as the skin of patients with psoriasis who have not yet shown symptoms of problems in these areas.

Mehta explains that FDG-PET/CT combines nuclear medicine—the branch of medicine that uses radiation and radioactive materials to diagnose and treat diseases—with two imaging technologies, PET and CT scans. It most frequently has been used for cancer imaging because this technique is able to show images of cancer cells, which are highly active, with great precision.

"This was a pilot study, meaning that it was the first attempt to test whether FDG-PET/CT can be used to detect inflammation in psoriasis and to understand if severe psoriasis affects critical organs beyond the skin," Mehta explained. "We have to keep in mind that the findings we report are based on a single study, and, thus, additional studies are necessary to confirm and extend our findings."

Commenting in Archives of Dermatology, University of Michigan researchers Drs. Johann E. Gudjonsson and Abhishek Aphale noted that, as one of the first studies to show objective evidence of inflammation in the blood vessels and liver of patients with psoriasis, Mehta's research "may eventually lead to earlier and more aggressive treatments and closer monitoring of patients with psoriasis."

Mehta says his next step in the research will be to test whether treating psoriasis with certain biologic drugs or with ultraviolet B phototherapy—treatments that reduce psoriasis inflammation—can also help calm inflammation throughout the body. He wants to understand whether these treatments will improve traditional and emerging risk factors for heart disease and diabetes.

He also hopes his research will raise awareness among medical providers who still consider psoriasis a cosmetic disease, and demonstrate the need to look beyond skin when confronting the disease.

Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Giving Tuesday save the date logo
#GivingTuesday gives you a worthwhile alternative to the holiday shopping...
Mason Zimmerman and Ethan Stafford at Team NPF Cycle
Meet the 12-year-old boys leading the next generation fighting against...
FDA APPROVED stamped on dab of cream
Clinical trials show new topical corticosteroid may help achieve clear or...
woman on sofa blowing her nose
Adopt these simple habits and stay healthy all winter.
Volunteers walking through the halls of Congress
NPF Advocacy Action Networks harness the power of many voices to support one...
There are more treatments now for PsA, but we still have a long way to go. NPF...
researchers in a lab
NPF just awarded more than $2 million in research grants and fellowships. Here’...
A recap of 2018 health care policy in the Golden State shows victories for...
Expanded availability of short-term plans may come with hidden costs and...